180 related articles for article (PubMed ID: 31035043)
21. Catalpol coordinately regulates phase I and II detoxification enzymes of Triptolide through CAR and NRF2 pathways to reduce Triptolide-induced hepatotoxicity.
Fu L; Zhou L; Geng S; Li M; Lu W; Lu Y; Feng Z; Zhou X
Biomed Pharmacother; 2020 Sep; 129():110379. PubMed ID: 32563148
[TBL] [Abstract][Full Text] [Related]
22. Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants.
Yoshinari K; Okino N; Sato T; Sugatani J; Miwa M
Drug Metab Dispos; 2006 Jul; 34(7):1081-9. PubMed ID: 16581946
[TBL] [Abstract][Full Text] [Related]
23. Differential Effects of Sunitinib on the Expression Profiles of Xenobiotic-Metabolizing Enzymes and Transporters in Rat Liver and Kidneys.
Korashy HM; Ansari MA; Maayah ZH; Imam F; Raish M; Attafi IM; Alharbi NO; Moraished BA
Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):173-83. PubMed ID: 26797788
[TBL] [Abstract][Full Text] [Related]
24. Modulation of NAD(P)H:quinone oxidoreductase by vanadium in human hepatoma HepG2 cells.
Abdelhamid G; Anwar-Mohamed A; Elmazar MM; El-Kadi AO
Toxicol In Vitro; 2010 Sep; 24(6):1554-61. PubMed ID: 20599494
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen sulfide-releasing aspirin modulates xenobiotic metabolizing enzymes in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Street CR; Velázquez-Martínez CA; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):733-40. PubMed ID: 22209714
[TBL] [Abstract][Full Text] [Related]
26. Introducing the "TCDD-inducible AhR-Nrf2 gene battery".
Yeager RL; Reisman SA; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 Oct; 111(2):238-46. PubMed ID: 19474220
[TBL] [Abstract][Full Text] [Related]
27. The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1alpha, CYP1A1 and NQO1 genes in rat liver.
Brauze D; Widerak M; Cwykiel J; Szyfter K; Baer-Dubowska W
Toxicol Lett; 2006 Dec; 167(3):212-20. PubMed ID: 17069994
[TBL] [Abstract][Full Text] [Related]
28. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
29. Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.
Cheng Q; Taguchi K; Aleksunes LM; Manautou JE; Cherrington NJ; Yamamoto M; Slitt AL
J Biochem Mol Toxicol; 2011; 25(5):320-9. PubMed ID: 21538727
[TBL] [Abstract][Full Text] [Related]
30. Renal toxicity through AhR, PXR, and Nrf2 signaling pathway activation of ochratoxin A-induced oxidative stress in kidney cells.
Lee HJ; Pyo MC; Shin HS; Ryu D; Lee KW
Food Chem Toxicol; 2018 Dec; 122():59-68. PubMed ID: 30291945
[TBL] [Abstract][Full Text] [Related]
31. Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.
Shah P; Guo T; Moore DD; Ghose R
Drug Metab Dispos; 2014 Jan; 42(1):172-81. PubMed ID: 24194512
[TBL] [Abstract][Full Text] [Related]
32. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics.
Sugatani J; Yamakawa K; Tonda E; Nishitani S; Yoshinari K; Degawa M; Abe I; Noguchi H; Miwa M
Biochem Pharmacol; 2004 Mar; 67(5):989-1000. PubMed ID: 15104253
[TBL] [Abstract][Full Text] [Related]
33. Persistent induction of hepatic and pulmonary phase II enzymes by 3-methylcholanthrene in rats.
Kondraganti SR; Jiang W; Jaiswal AK; Moorthy B
Toxicol Sci; 2008 Apr; 102(2):337-44. PubMed ID: 18203689
[TBL] [Abstract][Full Text] [Related]
34. Induction of rat UDP-glucuronosyltransferases in liver and duodenum by microsomal enzyme inducers that activate various transcriptional pathways.
Shelby MK; Klaassen CD
Drug Metab Dispos; 2006 Oct; 34(10):1772-8. PubMed ID: 16855052
[TBL] [Abstract][Full Text] [Related]
35. Effect of interferon-α2b on the expression of various drug-metabolizing enzymes and transporters in co-cultures of freshly prepared human primary hepatocytes.
Chen C; Han YH; Yang Z; Rodrigues AD
Xenobiotica; 2011 Jun; 41(6):476-85. PubMed ID: 21381897
[TBL] [Abstract][Full Text] [Related]
36. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.
Wu KC; Cui JY; Klaassen CD
PLoS One; 2012; 7(7):e39006. PubMed ID: 22808024
[TBL] [Abstract][Full Text] [Related]
37. Nrf2-dependent induction of NQO1 in mouse aortic endothelial cells overexpressing catalase.
Lin X; Yang H; Zhou L; Guo Z
Free Radic Biol Med; 2011 Jul; 51(1):97-106. PubMed ID: 21569840
[TBL] [Abstract][Full Text] [Related]
38. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
[TBL] [Abstract][Full Text] [Related]
39.
Chen CC; Lii CK; Lin YH; Shie PH; Yang YC; Huang CS; Chen HW
Am J Chin Med; 2020; 48(5):1073-1090. PubMed ID: 32668968
[TBL] [Abstract][Full Text] [Related]
40. Short-term calorie restriction feminizes the mRNA profiles of drug metabolizing enzymes and transporters in livers of mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2014 Jan; 274(1):137-46. PubMed ID: 24240088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
